CEBP Susan G. Komen for the Cure-AACR Outstanding Investigator Award for Breast Cancer Research Translational Cancer Medicine 2008: Cancer Clinical Trials and Personalized Medicine
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow reprints & permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Jones, I. M.
Right arrow Articles by Burkhart-Schultz, K.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Jones, I. M.
Right arrow Articles by Burkhart-Schultz, K.

Cancer Epidemiology Biomarkers & Prevention, Vol 2, Issue 3 249-260, Copyright © 1993 by American Association for Cancer Research


ARTICLES

Factors affecting HPRT mutant frequency in T-lymphocytes of smokers and nonsmokers

IM Jones, DH Moore, CB Thomas, CL Thompson, CL Strout and K Burkhart-Schultz
Biomedical Sciences Division, Lawrence Livermore National Laboratory, California 94551.

The frequency of thioguanine-resistant, hypoxanthine phosphoribosyltransferase-deficient lymphocytes in the peripheral blood of human subjects was used to study the genotoxic effects of smoking. Sixty-two nonsmokers and 58 smokers, aged 19 to 45 years with average ages of 30 and 32 years, respectively, and with no other known exposures, were studied using an in vitro assay of the frequency of mutant lymphocyte clones. Analysis of variance explained 68% of the variation in the mutant frequencies. Mutant frequency was dependent upon lymphocyte cloning efficiency, length of smoking history, age, and interactions between these variables. Four nonsmokers and three smokers had high mutant frequencies that were not explained by these variables. Mutant frequencies were inversely related to lymphocyte cloning efficiencies; the effect was twice as great for smokers as for nonsmokers. The time-dependent effect of smoking dominated, with mutant frequency increasing 10%/year of smoking as compared with an independent 1%/year of age. Smoking had a greater effect on young smokers' lymphocytes. Heterogeneity of mutant frequency among both smokers and nonsmokers and its implications for use of lymphocyte mutation assays as biomarkers are discussed.


This article has been cited by other articles:


Home page
MutagenesisHome page
J. L. Schwartz, R. Jordan, H. H. Evans, M. Lenarczyk, and H. L. Liber
Baseline levels of chromosome instability in the human lymphoblastoid cell TK6
Mutagenesis, November 1, 2004; 19(6): 477 - 482.
[Abstract] [Full Text] [PDF]


Home page
GeneticsHome page
J. Curry, L. Karnaoukhova, G. C. Guenette, and B. W. Glickman
Influence of Sex, Smoking and Age on Human hprt Mutation Frequencies and Spectra
Genetics, July 1, 1999; 152(3): 1065 - 1077.
[Abstract] [Full Text]


Home page
CarcinogenesisHome page
S.-M. Hou, K. Yang, F. Nyberg, K. Hemminki, G. Pershagen, and B. Lambert
Hprt mutant frequency and aromatic DNA adduct level in non-smoking and smoking lung cancer patients and population controls
Carcinogenesis, March 1, 1999; 20(3): 437 - 444.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Cancer Research Clinical Cancer Research
Cancer Epidemiology Biomarkers & Prevention Molecular Cancer Therapeutics
Molecular Cancer Research Cancer Prevention Research
Cancer Prevention Journals Portal Cancer Reviews Online
Annual Meeting Education Book Cell Growth & Differentiation
Copyright © 1993 by the American Association for Cancer Research.